Mai O. Kadry | Molecular Biology | Best Researcher Award

Assist. Prof. Dr. Mai O.Kadry | Molecular Biology | Best Researcher Award

Assist. Prof. Dr. Mai O.Kadry,National Research Center, Egypt

Dr. Mai Osman Mohamed Kadry is a distinguished biochemistry researcher at the Therapeutic Chemistry Department, National Research Centre, Egypt. With a Doctorate in Biochemistry from Cairo University (2016), her work focuses on oxidative injury, nanotoxicity, and cancer therapy. She has published extensively in high-impact journals on topics like antioxidant effects, stem cell therapies, and metabolic disorders. Dr. Kadry has also contributed to academia, teaching pharmacognosy at 6th October University. Skilled in advanced techniques like PCR, HPLC, and ELISA, she actively participates in groundbreaking nanobiotechnology research projects. Dr. Kadry is committed to advancing therapeutic strategies for critical diseases. πŸ“šπŸ§¬

Publication Profile

Scopus

Academic and Professional Experience πŸŒŸπŸŽ“

Assist. Prof. Dr. Mai O. Kadry has accumulated valuable experience in academia and research. She served as a pharmacognosy instructor at the Faculty of Pharmacy, 6th October University, Cairo, Egypt (2003–2004), where she effectively delivered courses on natural products and their therapeutic applications. Dr. Kadry also contributed as a staff member focused on development and quality enhancement, aligning with the standards of the National Commission for Academic Accreditation. Her dedication to education and quality assurance reflects her commitment to fostering academic excellence and professional growth in pharmaceutical sciences. πŸ“šπŸ”¬

 

Educational Background πŸŽ“πŸ“˜

Assist. Prof. Dr. Mai O. Kadry boasts a strong academic foundation in pharmaceutical sciences. She earned her Doctorate in Biochemistry from the Faculty of Pharmacy, Cairo University, in 2016, with a thesis on the “Amelioration of Nano-Sized Titanium Dioxide-Induced Oxidative Injury in Mice by Some Antioxidants.” She obtained her Master’s degree in Pharmaceutical Sciences from Helwan University in 2008, focusing on the synergistic effects of phytic and catechin on carbon tetrachloride-induced damage in rats. Dr. Kadry completed her B.Sc. in Pharmaceutical Science at Ain Shams University in 2003, graduating with honors. She also attended English language schools, enhancing her global communication skills. πŸŒŸπŸ”¬

 

Training πŸ§¬πŸ“š

Assist. Prof. Dr. Mai O. Kadry has undergone extensive training in various scientific disciplines. She completed courses in Biostatistics (November 2016) and Bioinformatics (January 2017) at the National Research Centre. Earlier, she gained expertise in Scientific Typewriting Bases (March 2007) and Occupational Health and Safety (June 2009). Additionally, she mastered Protein Electrophoresis through a four-month course in 2006. Dr. Kadry enhanced her practical skills with hands-on training at Al-Borg Clinical Laboratory, focusing on PCR techniques for detecting HBV and HCV at the Theodor Bilharz Research Institute. Her comprehensive training equips her with valuable laboratory and analytical skills. πŸ”¬πŸ§ͺ

 

Research Focus πŸ§ͺ🧠🧬

Assist. Prof. Dr. Mai O. Kadry focuses on cutting-edge biomedical research, emphasizing toxicity, cancer therapy, and molecular biology. Her work explores inflammatory mediators, DNA damage, and therapeutic approaches in liver, brain, and nephrotoxicity contexts. She investigates autophagy, necroptosis, and novel strategies like resveratrol nano-formulations for ovarian cancer. Dr. Kadry also studies molecular pathways in gastric and prostate cancers, including miRNA-lncRNA signaling and CRISPR-Cas9 applications. Other interests involve genetic mutations in leukemia, drug-delivery systems, and nanotechnology for breast cancer. Her contributions bridge diagnostics, therapeutic innovations, and cellular mechanisms in oncology and toxicology. πŸ”¬βœ¨

 

Publication Top Notes

  • Inflammatory mediators-induced DNA damage in liver and brain injury: Therapeutic approach of 5-Methoy-N-acetyltryptamine – 2024, Toxicology Reports 🧬
  • Necroptosis and autophagy in cisplatinum-triggered nephrotoxicity: Novel insights regarding prognostic and diagnostic potential – 2024, Toxicology Reports πŸ§ͺ
  • Resveratrol-based nano-formulations as a therapeutic strategy for ovarian carcinoma: Autophagy and SIRT-1 signaling – 2024, Cancer Nanotechnology πŸ’Š
  • miR-122-IGF-1R signaling allied with dysregulated lncRNA MALAT-1 in gastric carcinoma – 2024, Toxicology Reports πŸ”¬ (Cited by: 1)
  • Reciprocal crosslink among MeCP2/BDNF/CREB signaling in autism spectrum disorder – 2024, Toxicology Reports 🧠
  • CRISPR-Cas9 genome and lncRNAs for prostate cancer therapy via liposomal compounds – 2024, PLoS ONE 🧬 (Cited by: 1)
  • Collaboration of Hprt/K-RAS/c-Myc mutation in T-lymphocytic leukemia oncogenesis – 2024, Future Science OA πŸ§ͺ (Cited by: 1)
  • Thioctic acid shield against lipopolysaccharide depression and endoplasmic stress – 2024, Future Science OA 🧫
  • Titanium dioxide nanostructure-loaded Adriamycin in breast cancer therapy – 2024, Future Science OA πŸŽ—οΈ (Cited by: 1)
  • Alleviation of doxorubicin adverse effects via drug-delivery systems – 2024, Therapeutic Delivery πŸš‘

 

Zulqarnain Baloch | Biochemistry | Best Researcher Award

Zulqarnain Baloch | Biochemistry | Best Researcher Award

Prof Dr Zulqarnain Baloch, Kunming University of Science and Technology, China

Prof. Dr. Zulqarnain Baloch appears to be a highly suitable candidate for the Best Researcher Award due to several compelling factors:

Publication profile

google scholar

Research Excellence

  • PhD in Environmental Biology: Dr. Baloch’s doctoral research on the molecular epidemiology of Human Papillomavirus demonstrates his expertise in crucial areas of microbiology and molecular biology.
  • Highly Cited Publications: His publications on antibiotic resistance and its global implications highlight his significant contributions to addressing pressing health issues. Notably, the article “Antibiotic resistance: a rundown on global crisis” has been highly cited, reflecting its impact within the scientific community.

Research Grants and Funding

  • Dr. Baloch has successfully secured substantial funding for various research projects, totaling over 835,000 RMB. This includes funding for his postdoctoral work and the establishment of research platforms, indicating a strong capability to attract financial support for scientific endeavors.

Administrative and Teaching Roles

  • As the Head of the Bacteriology Department since September 2020, Dr. Baloch plays a pivotal role in guiding research and education in microbiology and molecular biology techniques.
  • He is involved in teaching critical subjects and has supervised several graduate students, contributing to the development of the next generation of researchers.

Honors and Awards

  • His recognition, including multiple Outstanding Thesis Awards and the title of Excellent International Graduate, speaks to his academic excellence and contributions to the field.

Professional Engagement

  • Dr. Baloch is an active member of various scientific societies and serves on editorial boards for several reputable journals, demonstrating his commitment to the advancement of science.

Community Engagement

  • His involvement in organizing international conferences and reviewing abstracts for significant scientific events showcases his dedication to fostering collaboration and knowledge exchange in the research community.

Publication top notes

Antibiotic resistance: a rundown of a global crisis

Antibiotic resistance: one health one world outlook

Starch-based antimicrobial films functionalized by pomegranate peel

Pathogenetic and therapeutic applications of tumor necrosis factor-Ξ± (TNF-Ξ±) in major depressive disorder: a systematic review

The impact of COVID-19 pandemic outbreak on education and mental health of Chinese children aged 7–15 years: an online survey

Prevalence and Characterization ofΒ Staphylococcus aureusΒ Cultured From Raw Milk Taken From Dairy Cows With Mastitis in Beijing, China

Enterotoxigenicity and Antimicrobial Resistance ofΒ Staphylococcus aureusΒ Isolated from Retail Food in China

Influence of ultrasound-assisted osmotic dehydration on texture, bioactive compounds and metabolites analysis of plum

Conclusion

Prof. Dr. Zulqarnain Baloch’s extensive research experience, significant funding accomplishments, teaching contributions, and recognition in the scientific community make him an outstanding candidate for the Best Researcher Award. His work not only contributes to the scientific literature but also addresses critical health challenges, making a tangible impact on public health and safety.

Asif shahzad | Medical Biochemistry | Best Researcher Award

Dr. Asif shahzad | Medical Biochemistry | Best Researcher Award

Dr. Asif shahzad, Kunming Medical University Yunnan China

Dr. Asif Shahzad is a Research Associate in Medical Biochemistry at Kunming Medical University, China, specializing in metabolic reprogramming of clear cell renal cell carcinoma (ccRCC). With 15+ international publications, his research also focuses on natural compounds in oncology and synbiotic feed supplements for poultry growth. He previously worked on HCV treatment and poultry nutrition at Government College University, Faisalabad, Pakistan. Dr. Shahzad actively collaborates with global researchers and is a member of several scientific organizations, contributing significantly to advancements in biochemistry and oncology. 🌱πŸ§ͺπŸ”¬

Publication profile

Google Scholar

Academic and Professional Background

Dr. Asif Shahzad is a Research Associate in Medical Biochemistry and Molecular Biology at Kunming Medical University, Yunnan, China, under the mentorship of Prof. Dr. Zhang Qiao. His work focuses on metabolic reprogramming in clear cell renal cell carcinoma (ccRCC), with 15+ publications in high-impact journals. Previously, he contributed to research at Government College University, Faisalabad, Pakistan, exploring serine protease inhibitors for HCV treatment and developing synbiotic feed supplements for poultry under the guidance of Prof. Dr. Shagufta Kamal. He is an active member of various biochemistry and oncology societies, demonstrating a strong commitment to advancing scientific knowledge.

Research and Innovations

Dr. Shahzad has participated in numerous research projects. He was a Research Associate on an HEC-funded project that explored serine protease inhibitors as a novel therapeutic approach for HCV. He also contributed to a PHEC project developing a synbiotic feed supplement for poultry. Currently, he leads a project on bioactive peptides from plant species and their potential therapeutic effects against HCV. His ongoing research includes a study on Moringa oleifera’s anti-ccRCC properties. His work exemplifies a versatile research portfolio that bridges human health and animal nutrition innovations.

Areas of Research

Dr. Shahzad’s research interests span several fields, including metabolic reprogramming in cancer, natural compounds in oncology, synbiotics in animal nutrition, amino acid analysis, and biocatalysis. His multidisciplinary research combines both human and animal health sciences, showcasing his ability to contribute to diverse scientific fields.

Publication Top Notes

  • An overview of free Radicals & antioxidants and its Deleterious actions πŸ§ͺπŸ“š A Shahzad, S Hussain, N Anwar, A Karim, U Aeman, MJ Iqbal | Cited by 4 | 2021
  • Modulation of Metabolic Pathways and Protection against Cadmium-Induced Disruptions with Taxifolin-Enriched Extract πŸ§¬πŸ›‘οΈ MF Khalid, MSH Akash, K Rehman, A Shahzad, A Nadeem | Cited by 1 | 2024
  • Biochemical investigation of association of arsenic exposed polymorphic variants and disease susceptibility πŸ”¬πŸ§¬ SM Shoaib, S Afzal, MSH Akash, K Rehman, A Hussain, A Nadeem, A Shahzad | 2025
  • Innovative lipid nanoparticles: A cutting-edge approach for potential renal cell carcinoma therapeutics πŸ’ŠπŸ§« A Shahzad, Z Teng, M Yameen, W Liu, K Cui, X Liu, Y Sun, Q Duan | 2024
  • Therapeutic Intervention of Serine Protease Inhibitors against Hepatitis C Virus πŸ¦ πŸ’Š S Kamal, A Shahzad, K Rehman, K Tariq, MSH Akash, M Imran, MA Assiri | 2024
  • Biochemical Investigation of Therapeutic Efficacy of Berberine-Enriched Extract in Streptozotocin-Induced Metabolic Impairment πŸ§ͺ🩺 MSH Akash, S Yaqoob, K Rehman, A Hussain, Z Chauhdary, A Nadeem, A Shahzad | 2024
  • Biosynthesis and Multifaceted Characterization of Breynia nivosa-Derived Silver Nanoparticles: An Eco-Friendly Approach for Biomedical Applications πŸŒΏβš—οΈ K Irshad, MSH Akash, K Rehman, A Nadeem, A Shahzad | 2024
  • The Impact of Gut Bacterial Metabolites on Brain Disorder 🧠🦠 A Shahzad, S Hussain, R Mehmood, MN Jaan | 2022
  • A Medical Approach for Rhinoplasty πŸ‘ƒπŸ©Ί A Shahzad, S Hussain, A Karim, HMA Farooq, S Azam, U Hameed | 2022
  • Impact of Obesity in Male and Female Infertility βš–οΈπŸ§¬ DEM Razia, A Shahzad, S Hussain, NB Qureshi, N Anwaar, A Aftab | 2021


Conclusion

Dr. Asif Shahzad’s innovative research in cancer metabolism and animal nutrition, combined with his editorial, collaborative, and professional contributions, makes him a strong candidate for the Best Researcher Award. His research’s impact on both human and animal health sectors aligns with the award’s recognition of excellence and innovation in scientific inquiry.

 

Wael El-Sayed | Biochemistry | Best Researcher Award

Prof Dr. Wael El-Sayed | Biochemistry | Best Researcher Award

Professor, Faculty of Science – Ain Shams University, Egypt

Dr. Wael M. El-Sayed is a distinguished Professor of Animal Physiology and Toxicology at Ain Shams University, Cairo, Egypt. With over 30 years of experience, he has made significant contributions to physiology, toxicology, and drug development. His research, which spans natural products, drug interactions, and biochemical toxicology, has garnered him a notable academic reputation. Dr. El-Sayed holds an impressive record with 78 articles in international peer-reviewed journals and has been cited over 1,400 times. πŸŒπŸ“š

 

Publication Profile

 

Strengths for the Award:

  1. Extensive Research Output: Dr. Wael M. El-Sayed has published 78 articles in international peer-reviewed journals, which demonstrates a strong commitment to advancing scientific knowledge in toxicology and physiology.
  2. Impact and Recognition: His work has garnered significant recognition in the scientific community, with a high number of citations across Google Scholar (1462), Scopus (1108), and ResearchGate (1242). His h-index values (22 on Google Scholar, 21 on Scopus, and 20 on ResearchGate) further indicate the influence and relevance of his research.
  3. Diverse Research Platforms: Dr. El-Sayed maintains active profiles on multiple research platforms, including Scopus, ORCID, Web of Science, and ResearchGate, which reflects his engagement with the broader scientific community and his dedication to maintaining visibility and accessibility of his work.
  4. Experience and Expertise: As a Professor of Toxicology and Physiology at a reputable institution (University of Ain Shams), Dr. El-Sayed has significant academic and research experience, further solidifying his expertise in his field.

Areas for Improvement:

  1. Interdisciplinary Collaboration: While Dr. El-Sayed has a strong background in toxicology and physiology, increasing collaboration with researchers in other related fields (e.g., molecular biology, environmental science) could potentially expand the impact and applicability of his research.
  2. Research Funding and Projects: Securing more prominent research grants and leading high-impact projects could further enhance Dr. El-Sayed’s research profile, providing additional resources and opportunities to advance his work.
  3. Global Recognition: While Dr. El-Sayed has significant citations and publications, expanding his research reach through international conferences, collaborations, and workshops could increase his global recognition and further establish him as a leading expert in his field.

 

Education πŸŽ“

Ph.D. in Physiology from Ain Shams University, Egypt, and the University of Utah, USA (2003). Thesis: “Mechanisms of therapeutic activities of Nigella Sativa against lipid peroxidation and hepatotoxicity in male albino rats. “M.Sc. in Physiology from Ain Shams University, Cairo, Egypt (1999). Thesis: “Effect of Nigella Sativa on some physiological and biochemical parameters in male albino rats. “B.Sc. in Science from Ain Shams University, Cairo, Egypt (1993).

Experience πŸ’Ό

Professor of Animal Physiology and Toxicology, Zoology Department, Ain Shams University (2014-Present). Associate Professor, Zoology Department, Ain Shams University (2009-2014). Associate Professor, Biology Department, King Faisal University, KSA (2007-2013). Assistant Professor, Zoology Department, Ain Shams University (2003-2009). Post-Doctoral Fellow, Department of Pharmacology and Toxicology, University of Utah (2004-2006). Assistant Lecturer and Demonstrator at Ain Shams University (1994-1999).

Research Focus πŸ”¬

Dr. El-Sayed’s research interests include:

Natural products and their therapeutic effects, Drug-drug interactions and drug metabolism, Chemoprotection and chemoprevention strategies in cancer, Antioxidants and biochemical toxicology, Molecular Biology and Biotechnology

Awards and Honours πŸ†

2020: Impact of Zinc Oxide-Sea Lettuce Nanocomposite study funded by STDF. 2018: Novel bithiophenes synthesis and anticancer activity project funded by Mansoura University. 2017: Molecular and biological characterization of recombinant human interferon alpha 2b, funded by STDF.

Publication Top Notes πŸ“‘

Ahmed DH, El-Beih NM, El-Hussieny EA, El-Sayed WM. “Large diameter zinc oxide nanoparticles reduced testicular CYP17A1 and viability and elevated testicular inflammation in adult male rats.” Under Review.

EL-Azma MHA, EL-Beih NM, EL-Shamy KA, Koriem KMM, EL-Kassaby MI, EL-Sayed WM. “Pumpkin seed oil exerted antidepressant effects through ameliorating oxidative stress and neuroinflammation in the hippocampus of depressed rats.” Under Review.

Mahmoud MM, El-Batran SA, Hegazy R, El-Sayed WM. “Taurine and enzymatically modified isoquercitrin synergistically protect against methotrexate-induced cardiotoxicity in rats: antioxidant and antiapoptotic effects.” Under Review.

Qasem HH, El-Sayed WM. “The bacterial microbiome and cancer: development, diagnosis, treatment, and future directions.” Under Review.

AbdulKhaliq RJ; Alwandawi1 TK, Al-Hamadani MYI, El-Sayed WM. “Immunological Impact of Vaccination on INF-Ξ³ and TNF-Ξ± Levels: Gender Disparities and Infection Status Modulation in Iraq Subjects.” Under review.

 

Conclusion:

Dr. Wael M. El-Sayed is a highly qualified candidate for the Best Researcher Award, with a strong research background, significant contributions to his field, and a well-established presence in the scientific community. His extensive publication record and high citation count demonstrate his influence in toxicology and physiology. However, there is potential for further growth through interdisciplinary collaboration, increased research funding, and greater global engagement. Overall, Dr. El-Sayed’s achievements and ongoing contributions make him a compelling candidate for this award.

 

Chloe FERAL | Biochemistry | Best Researcher Award

Chloe FERAL | Biochemistry | Best Researcher Award

Mrs Chloe FERAL, INSERM, France

Based on Mrs. ChloΓ© FΓ©ral’s impressive credentials and contributions, she appears to be a highly suitable candidate for the Best Researcher Award.

Publication profile

Orcid

Research Excellence and Achievements

Current Position: Research Director (DR2) at INSERM, France, with significant roles in leading the “Epithelial homeostasis and tumorigenesis” team at IRCAN. Education: Acquired a PhD with honors and Habilitation (HDR), showcasing a strong foundation in Cell and Molecular Pharmacology. Awards and Fellowships: Received prestigious awards such as the Sanofi iAward and multiple grants from INCA and ARC, highlighting her contributions to translational research and cancer studies.

Research Contributions

Publications: Authored numerous high-impact journal articles, including in Scientific Reports, Cell Death & Differentiation, and International Journal of Molecular Sciences. Her research spans critical areas like epithelial homeostasis, tumorigenesis, and cancer biology. Patents: Holds a patent for methods and compositions for treating skin afflictions, demonstrating her innovative approach in research.

Leadership and Impact

Organizational Roles: Organized major scientific meetings and held several institutional responsibilities, such as serving on scientific advisory boards and council boards. Teaching Activity: Actively involved in teaching and training, including lecturing at prestigious institutions like the Γ‰cole Polytechnique Paris.

Scientific Community Engagement

Memberships and Committees: Engaged in various scientific societies and committees, contributing to the evaluation and guidance of research and academic activities.

Notable Research Highlights

Her work on epithelial stem cell fate and tumorigenesis, as well as advancements in cancer research, underlines her role as a leading figure in her field.

Awards

Dr. Chloe FERAL has been recognized for significant contributions in translational research. As Principal Investigator (PI), they led the Sanofi iAward EUROPE for Translational Research (2020-2021) and secured the PL-Bio Grant from INCA (2019-2023), collaborating with a team consortium. They also received the IDEX-UCAJEDI Prematuration grant from the University CΓ΄te d’Azur (2019-2020). The Excellency Program from “La Ligue Contre le Cancer” (2014-2018) and the COPOC2018 Inserm Transfert Award (2018) further highlight their achievements. Additionally, Dr. [Name] received ARC Project Awards in 2016-2017 and 2018-2019. πŸ†πŸ”¬πŸ§¬

Publication top notes

The biophysical property of the limbal niche maintains stemness through YAP

Fibroblast growth factor-2 bound to specific dermal fibroblast-derived extracellular vesicles is protected from degradation

Lung Adenocarcinoma Tumor Origin: A Guide for Personalized Medicine

Fibronectin meshwork controls epithelial stem cell fate

Soft limbal niche maintains stem cell compartmentalization and function through YAP

A ganglioside-based senescence-associated immune checkpoint

A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy.

 

 

Hyunsook Lee | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Prof Dr Hyunsook Lee | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Professor, Head of SNU AI-Bio Research Center,Seoul National University/College of Natural Sciences/Dept. of Biological Sciences, South KoreaΒ 

Dr. Hyunsook Lee is a distinguished professor in the Department of Biological Sciences and the Institute of Molecular Biology and Genetics at Seoul National University (SNU) πŸ‘©β€πŸ”¬πŸ“š. As the Head of the AI-Bio Research Center at SNU πŸ§ πŸ”¬, she is a leading figure in integrating artificial intelligence with molecular biology to advance personalized medicine and cancer research πŸ§¬πŸ€–. Dr. Lee holds a Ph.D. from the University of Cambridge, where her research on cell cycle checkpoints and the BRCA2 gene significantly contributed to our understanding of breast cancer πŸ”¬. She has held esteemed positions at Harvard Medical School and the University of Washington during her postdoctoral studies and has received numerous awards, including the Wellcome Trust International Prize and the POSCO Chungam Science Award πŸ†. Beyond her research, Dr. Lee serves on multiple advisory committees for the Korean government and various scientific organizations πŸ“ˆπŸ›οΈ. Her dedication to science, education, and innovative research has established her as a highly respected leader in her field 🌟.

Publication profile

Scopus

Education

Dr. Hyunsook Lee πŸŽ“ embarked on her academic journey with a Bachelor’s degree in Biology from Ewha Womans University (1986. Mar – 1990. Feb) 🏫. She then pursued a Master’s degree in Biology at Seoul National University (1990. Mar -1992. Feb) πŸŽ“. Her passion for molecular biology led her to the University of Cambridge in the UK, where she earned her Ph.D. (1996. Oct – 1999. Sept) πŸ‡¬πŸ‡§. Her doctoral research focused on “Cell cycle checkpoints and the breast cancer susceptibility gene, Brca2” πŸ“–, under the supervision of Prof. Ashok Venkitaraman and Dr. Michael Neuberger, FRS. Her thesis was examined by Sir Tim Hunt, a Nobel Laureate (2001), and Prof. Jonathan Pines 🧬. Following her Ph.D., she received the Wellcome Trust Postdoctoral Fellowship (Wellcome Trust International Prize) πŸ†, working with Prof. Frank McKeon at Harvard Medical School (2000. Jan ~ 2000. Aug) πŸ₯ and Prof. David Kimelman at the University of Washington, Seattle (2000. Aug ~ 2002. Sept) 🧫.

Professional Experience

Dr. Hyunsook Lee has had a distinguished professional career in academia and research πŸ‘©β€πŸ”¬. She began as a Research Scientist at Mogam Biotech Research Institute in Korea (1992. Mar – 1994. May) πŸ”¬ and was promoted to Senior Research Scientist (1994. May – 1996. Aug) 🧬. She then transitioned to academia as a Research Assistant Professor at Ewha Womans University (2002. Sept – 2003) πŸ§ͺ. In 2004, she joined the Dept. of Biological Sciences at Seoul National University (SNU) as an Assistant Professor πŸ“š, advancing to Associate Professor in 2008 and earning early tenure in 2010 🌟. By 2012, she became a full Professor at SNU 🌍. Dr. Lee has also served in several key administrative roles, including Vice Dean of Planning for the College of Natural Sciences (2015 July – 2017 June) πŸ“…, and Dean for Research Affairs at SNU (2021. Feb – 2023. Feb) πŸŽ“. She has been the Head of the AI-Bio Research Center since 2023 πŸ§ πŸ”¬ and co-founded Next & Bio in 2019, which later merged with Kolmar Holdings in 2022 πŸ’Ό. Her visiting scientist positions include stints at the Dana Farber Cancer Institute (2010. Aug – 2011. July) 🧬 and Samsung Advanced Institute of Technology (2020. Aug – 2021. Feb) πŸ₯.

Certificates

Dr. Hyunsook Lee holds prestigious certificates including the Wellcome Trust International Prize for her postdoctoral fellowship πŸ†, and recognition from the POSCO Bessemer Science Fellowship and POSCO Chungam Science Award πŸ…. Her expertise and contributions to molecular biology and cancer research have been widely acknowledged through these esteemed honors πŸŽ–οΈ.

Research Interest

Dr. Hyunsook Lee’s research interests are centered on the intersection of molecular biology, cancer research, and artificial intelligence πŸ§¬πŸ€–. She is particularly focused on cell cycle checkpoints and the roles of genes such as BRCA2 in breast cancer susceptibility πŸ”¬. Her work aims to elucidate the molecular mechanisms underlying cancer development and progression, with the ultimate goal of identifying new therapeutic targets and strategies for cancer treatment πŸ₯. Additionally, as the Head of the AI-Bio Research Center at Seoul National University πŸ§ πŸ”¬, Dr. Lee is at the forefront of integrating AI technologies with biological research to advance personalized medicine and enhance predictive models for disease outcomes πŸ“ˆ. Her innovative approach combines traditional molecular biology with cutting-edge AI, striving to push the boundaries of what is possible in biomedical research and healthcare innovation 🌟.

Award and Honor

Dr. Hyunsook Lee has been the recipient of numerous prestigious awards and honors throughout her illustrious career πŸŽ–οΈ. She was awarded the Wellcome Trust International Prize for her postdoctoral fellowship, recognizing her outstanding contributions to molecular biology πŸ†. Her groundbreaking research has earned her accolades from various scientific organizations, including the POSCO Chungam Science Award and the POSCO Bessemer Science Fellowship πŸ…. In 2021, she was appointed to several high-profile advisory committees, such as the Advisor Committee for STEPI, the Ministry of Education, and the Ministry of SMEs & Startups in Korea πŸ“ˆπŸ«. Additionally, Dr. Lee has been honored with leadership roles, including her tenure as Dean for Research Affairs at Seoul National University and her current position as Head of the AI-Bio Research Center πŸ§ πŸ”¬. Her contributions to science and education have made her a highly respected figure in the academic and research communities 🌟.

Research Skill

Dr. Hyunsook Lee possesses a diverse and robust skill set in research, particularly in molecular biology, cancer biology, and the application of artificial intelligence in biomedical research πŸ§¬πŸ€–. She is adept in techniques such as cell cycle analysis, gene cloning, and protein expression and purification πŸ”¬. Her expertise extends to advanced genomic technologies, including CRISPR-Cas9 gene editing and next-generation sequencing (NGS) 🧫. Dr. Lee is also skilled in bioinformatics and computational biology, employing AI and machine learning algorithms to analyze complex biological data and develop predictive models for disease outcomes πŸ“Š. Her proficiency in these areas enables her to conduct cutting-edge research that bridges traditional experimental biology with modern computational approaches, driving forward innovative solutions in cancer treatment and personalized medicine πŸ₯🌟.

Publications

  • Kim, H., Jang, J., Choi, J.H., … Lee, J.K., Park, J.K.
    • Title: Establishment of a patient-specific avatar organoid model derived from EUS-guided fine-needle biopsy for timely clinical application in pancreatic ductal adenocarcinoma (with video)
    • Journal: Gastrointestinal Endoscopy, 2024
    • Volume: 100
    • Issue: 1
    • Pages: 85–96.e9
  • Lee, J.J., Kim, H., Park, H., … Han, W., Lee, H.
    • Title: Disruption of G-quadruplex dynamicity by BRCA2 abrogation instigates phase separation and break-induced replication at telomeres
    • Journal: Nucleic Acids Research, 2024
    • Volume: 52
    • Issue: 10
    • Pages: 5756–5773
  • Youk, J., Kwon, H.W., Lim, J., … Son, T.G., Ju, Y.S.
    • Title: Quantitative and qualitative mutational impact of ionizing radiation on normal cells
    • Journal: Cell Genomics, 2024
    • Volume: 4
    • Issue: 2
    • Article: 100499
  • Koh, Y., Kim, H., Joo, S.Y., … Yoon, S.-S., Park, J.K.
    • Title: Genetic assessment of pathogenic germline alterations in lysosomal genes among Asian patients with pancreatic ductal adenocarcinoma
    • Journal: Journal of Translational Medicine, 2023
    • Volume: 21
    • Issue: 1
    • Page: 730
  • Lee, J., Sung, K., Joo, S.Y., … Kim, S.K., Lee, H.
    • Title: Dynamic interaction of BRCA2 with telomeric G-quadruplexes underlies telomere replication homeostasis
    • Journal: Nature Communications, 2022
    • Volume: 13
    • Issue: 1
    • Page: 3396
  • Kim, Y., Park, J., Joo, S.Y., … Lee, H., Cho, Y.
    • Title: Structure of the Human TELO2-TTI1-TTI2 Complex
    • Journal: Journal of Molecular Biology, 2022
    • Volume: 434
    • Issue: 2
    • Page: 167370
  • Park, J., Yeu, S.Y., Paik, S., … Koh, Y., Lee, H.
    • Title: Loss of BubR1 acetylation provokes replication stress and leads to complex chromosomal rearrangements
    • Journal: FEBS Journal, 2021
    • Volume: 288
    • Issue: 20
    • Pages: 5925–5942
  • The, F., Lee, H.
    • Title: Editor Profile: Hyunsook Lee
    • Journal: FEBS Journal, 2021
    • Volume: 288
    • Issue: 15
    • Pages: 4439–4441
  • Lee, J.J., Lee, J., Lee, H.
    • Title: Alternative paths to telomere elongation
    • Journal: Seminars in Cell and Developmental Biology, 2021
    • Volume: 113
    • Pages: 88–96
  • Ma, X., Song, S., Kim, S., … Park, W., Sim, S.J.
    • Title: Single gold-bridged nanoprobes for identification of single point DNA mutations
    • Journal: Nature Communications, 2019
    • Volume: 10
    • Issue: 1
    • Page: 836